Paper 2: EUROCAT public health indicators for congenital anomalies in Europe.
about
Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to studentsGenetic dissection of the Down syndrome critical region.Pregnancy complications in HIV-positive women: 11-year data from the Frankfurt HIV Cohort.Geographic and urban-rural disparities in the total prevalence of neural tube defects and their subtypes during 2006-2008 in China: a study using the hospital-based birth defects surveillance system.A new cognitive evaluation battery for Down syndrome and its relevance for clinical trialsChanges in detection of birth defects and perinatal mortality after introduction of prenatal ultrasound screening in the Kola Peninsula (North-West Russia): combination of two birth registries.Periconceptional folate deficiency and implications in neural tube defects.Prevalence of Congenital Anomalies in an Indian Maternal Cohort: Healthcare, Prevention, and Surveillance Implications.Long term trends in prevalence of neural tube defects in Europe: population based studyPatterns of folic acid use in pregnant Saudi women and prevalence of neural tube defects - Results from a nested case-control study.Weaker control of the electrical properties of cerebellar granule cells by tonically active GABAA receptors in the Ts65Dn mouse model of Down's syndrome.Prenatal ultrasound screening for fetal anomalies and outcomes in high-risk pregnancies due to maternal HIV infection: a retrospective study.Combined Treatment With Environmental Enrichment and (-)-Epigallocatechin-3-Gallate Ameliorates Learning Deficits and Hippocampal Alterations in a Mouse Model of Down Syndrome.The risk for four specific congenital heart defects associated with assisted reproductive techniques: a population-based evaluationAssessing the role of multiple pregnancies in the association between tetralogy of Fallot and assisted reproductive techniques: a path-analysis approach.Trends in the prevalences of congenital anomalies and age at motherhood in a Southern European region: a population-based study.A population-based registry as a source of health indicators for rare diseases: the ten-year experience of the Veneto Region's rare diseases registry.Time trends in the prevalence and epidemiological characteristics of neural tube defects in Liaoning Province, China, 2006-2015: A population-based study.The evolution of prenatal screening and diagnosis and its impact on an unselected population over an 18-year period.Prevention of myelomeningocele: African perspectives.Preventing birth defects: The value of the NBDPS case-control approach.Estimating Global Burden of Disease due to congenital anomaly: an analysis of European data.The Impact of Different Case Ascertainment Definitions on the Prevalence of Major Congenital Malformations and their Association with Asthma During Pregnancy.Mouse-based genetic modeling and analysis of Down syndrome.Spatial and temporal clustering of isolated cleft lip with or without cleft palate in Poland.Contingent non-invasive prenatal testing: an opportunity to improve non-genetic aspects of fetal aneuploidy screening.Using scan statistics for congenital anomalies surveillance: the EUROCAT methodology.Disparities in treatment rates of paediatric end-stage renal disease across Europe: insights from the ESPN/ERA-EDTA registry.Is the probability of prenatal diagnosis or termination of pregnancy different for fetuses with congenital anomalies conceived following assisted reproductive techniques? A population-based evaluation of fetuses with congenital heart defects.Prevalence of neural tube defect in southern Thailand: a population-based survey during 2009-2012.Measurement of nuchal translucency for prenatal screening of congenital heart defects: a population-based evaluation.Clinical and socioeconomic predictors of pregnancy termination for fetuses with congenital heart defects: a population-based evaluation.A national cohort study evaluating infant and fetal mortality caused by birth defects in Korea.Rodent models in Down syndrome research: impact and future opportunities.Primary Prevention of Congenital Anomalies: Special Focus on Environmental Chemicals and other Toxicants, Maternal Health and Health Services and Infectious Diseases.DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives.Triplications of human chromosome 21 orthologous regions in mice result in expansion of megakaryocyte-erythroid progenitors and reduction of granulocyte-macrophage progenitors.A structurally normal fetus at the 11- to 14-week ultrasound does not guarantee a newborn without congenital anomalies: a cohort study.EUROCAT: an update on its functions and activities
P2860
Q28077671-DD680AEB-EF24-489E-807E-5BAA2309C81EQ30670043-9E01E33B-6529-494B-BD8D-5EAED0260831Q30772144-5EE3B852-AF75-49F4-9448-F3812D6DED1BQ34596167-2E4BFF5E-AF3C-41A6-84CA-706F4BD21275Q35682486-0C5865E0-639E-4355-953E-CB7CECBD8EA0Q35848915-C8CC0923-F9D1-4E96-B6E1-F8EFCDCFB3F2Q36151451-96CBD26B-BB59-4207-8AA1-7BCAC8E2D1E6Q36188645-862277C7-62B2-4195-90F6-3A30495A0C45Q36316162-FF7A51AA-EDC7-4B9C-BC23-A982724A4D76Q36486528-78F189B7-7AFC-488C-B303-757C1A3AA20EQ37045414-14F45F8E-5B1D-4662-B9B8-ECE993FA7653Q37243085-9F2A92F5-8913-48E8-9F43-648E8FB99F24Q37399704-6D8610DD-35AD-4A8B-B2D9-7E30AE30AE01Q37418182-EDEEE7B4-59E5-4469-93E2-4640C48A602BQ37600897-452D27A8-EE04-49A1-84C0-825070E7AD11Q37628584-3A80ED42-6AB8-4253-96A1-6748B97EA3EBQ37723828-8C338828-0E7B-4C07-B896-BDAE09974BE4Q37725576-C4B9E623-A06C-4702-ABD5-CAEDA191C818Q38016971-76FE92CE-988D-4DA0-9CB8-8C9C5DDD8E2CQ38135233-880D3CF9-F324-4F0D-BF8D-1EBD3D6F8391Q38546831-E5E6FD04-14AF-4E63-AC5F-B8A9F79A8C68Q38699297-A9AABA61-0DDF-4F17-BE1B-CF0EC7A6CED9Q38839160-EA64070C-D7D6-4E62-B49C-06A6137A1C5EQ38993138-2CC187C9-8D33-44E8-9978-4F7415B2E4D5Q40172699-9209F2B1-DF91-4ABF-B37C-A01E95AD8609Q40459322-38704BFB-0F3B-4D66-B4D9-45933020F990Q40886796-313B2B3F-8492-4C54-84C5-4EC7A322A1DBQ41118634-D33E34CB-F740-49B1-BF39-313845788326Q41264527-180EFE66-29F1-4D52-8DA6-9A928724856CQ44087671-C0B007BB-5789-4312-849F-CC2276B3405EQ45028129-FC7752B2-8F59-4C68-8D82-6E43E733EDCBQ45181290-3BA95E50-8800-4D7A-88E4-13DAA6330CE8Q46142922-4295C731-4CCA-4ACE-9BE9-401F499192F7Q46193918-23846EF6-BB67-444C-889A-53C24634C76EQ47583984-2891EB9D-527E-400E-AABF-17A2DBF522E1Q49632429-8521C4DA-7D0D-465B-A526-0763190BE789Q49757490-564639EE-5DC7-42AB-8181-5F6534BADA0AQ53180375-93495D66-DE20-4E33-9BEB-2DE54A96223CQ57077325-7115F1AB-817C-4709-9144-398B1206412D
P2860
Paper 2: EUROCAT public health indicators for congenital anomalies in Europe.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Paper 2: EUROCAT public health indicators for congenital anomalies in Europe.
@ast
Paper 2: EUROCAT public health indicators for congenital anomalies in Europe.
@en
type
label
Paper 2: EUROCAT public health indicators for congenital anomalies in Europe.
@ast
Paper 2: EUROCAT public health indicators for congenital anomalies in Europe.
@en
prefLabel
Paper 2: EUROCAT public health indicators for congenital anomalies in Europe.
@ast
Paper 2: EUROCAT public health indicators for congenital anomalies in Europe.
@en
P2093
P2860
P356
P1476
Paper 2: EUROCAT public health indicators for congenital anomalies in Europe.
@en
P2093
EUROCAT Project Management Committee
EUROCAT Working Group
Helen Dolk
Ruth Greenlees
P2860
P304
P356
10.1002/BDRA.20776
P478
91 Suppl 1
P577
2011-03-04T00:00:00Z